Sykehusinnkjøp HF 916 879 067 Hermetikken Tollbugata 7 Vadsø 9800 Silje Bjelland +47 93491234 silje.bjelland@sykehusinnkjop.no http://sykehusinnkjop.no High capacity sequencing instruments 2017/1618 Sykehusinnkjøp Health Trust wants, on behalf of Helse Stavanger Health Trust, to enter into a purchasing agreement for 1 High capacity sequencing equipment with accompanying instrument dependent consumables. The Instrument shall be delivered to the Centre for medical microbiology at the Stavanger University Hospital. The instrument is intended for microbiological sample material for full genome sequencing and meta genome sequencing. 3000000.00 Sykehusinnkjøp Health Trust wants, on behalf of Helse Stavanger Health Trust, to enter into a purchasing agreement for 1 High capacity sequencing equipment with accompanying instrument dependent consumables. The Instrument shall be delivered to the Centre for medical microbiology at the Stavanger University Hospital. The instrument is intended for microbiological sample material for full genome sequencing and meta genome sequencing. The equipment is also intended for antibiotics research. One instrument. The justification for implementing the procurement as a Voluntary ex ante transparency notice is based on the hospital's necessary need for increased capacity, combined with a “back-up instrument” for already existing instruments that consist of NextSeq and a MiSeq from Illumina. It is therefore decisive that there is an available “back-up instrument” amongst the department's instruments. By choosing a new instrument from Illumina (MiSeq), all the instruments will be able to function as a back-up for each other, independent of analysis. The procurement of a new instrument from another supplier than Illumina would require a very extensive validation process, which could mean that the goal and increased capacity combined with a “back-up function” are not fulfilled. In addition to the medical reasons, it would also be very demanding on resources to get a new instrument from another supplier than Illumina. This will result in large additional investment costs. Conclusion: Based on the mentioned justifications, the Contracting Authority believes that there is a legal basis to enter into a contract for the procurement of high capacity instrument and the accompanying instrument dependent consumables with Illumina Norway AS, without announcing a competition, cf. Public Procurement Regulations (PPR [FOA]) § 21-5, cf. § 13-4 1 st chapter, Letter b, 2 nd point. 2018-06-08 Illumina Norway AS 819 187 002 Oslo 12000000.00 Sykehusinnkjop HF Vadsø 2018-06-11
See tender at TED: http://ted.europa.eu/udl?uri=TED:NOTICE:251990-2018:TEXT:EN:HTML